Therapeutic effect of osimertinib plus cranial radiotherapy compared to osimertinib alone in NSCLC patients with EGFR-activating mutations and brain metastases: a retrospective study

BACKGROUND: The study aimed to compare the efficacy of osimertinib plus cranial radiotherapy (RT) with osimertinib alone in advanced non-small-cell lung cancer (NSCLC) patients harboring epidermal growth factor receptor (EGFR) mutations and brain metastases (BMs). METHODS: The clinical data of advan...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Xiaoyang, Li, Wanhu, Li, Ji, Jia, Wenxiao, Jing, Wang, Tian, Yaru, Xu, Shuhui, Li, Yuying, Zhu, Hui, Yu, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647301/
https://www.ncbi.nlm.nih.gov/pubmed/34865626
http://dx.doi.org/10.1186/s13014-021-01955-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647301/
https://www.ncbi.nlm.nih.gov/pubmed/34865626
http://dx.doi.org/10.1186/s13014-021-01955-7

Ejemplares similares